Search results for "Highlights"


 
Results 41 - 50 of about 120 for "Highlights".

Highlights

The increase primarily occurred among people who reported drug use or homelessness.
May 2019

Highlights

Patients with inflammatory bowel disease were diagnosed with dementia an average of seven years earlier than matched controls in a Taiwanese study.
June 2020

Highlights

A multicenter randomized trial in Japan found that a single surveillance colonoscopy three years postpolypectomy and two surveillance colonoscopies at one and three years were similarly accurate for detecting clinically important neoplastic lesions.
November 2020

Highlights

Participation was higher and more colorectal cancer (CRC) and advanced adenomas were detected with repeated fecal immunochemical testing (FIT) compared to sigmoidoscopy, although the risks of perforation and bleeding were comparable.
December 2020

Highlights

The CDC called for hepatitis C virus (HCV) testing of both the patient and exposed personnel as soon as possible after an exposure incident, preferably within 48 hours.
August 2020

Highlights

Using clinical variables identified from simple machine learning in a cirrhosis mortality model produced a new score that was more transparent than a commonly used version of the Model for End-Stage Liver Disease, a study found.
November 2020

Highlights

The American Gastroenterological Association said that diagnosis of seronegative celiac disease, the most common cause of seronegative enteropathy, can be complicated by misinterpretation of histological findings, insufficient serological testing,
October 2020

Highlights

While NSAIDs and a high consumption of fruits and vegetables were associated with a decreased incidence of colorectal cancer, frequent consumption of alcohol or meat was linked to increased colorectal cancer incidence, a systematic review found.
October 2020

Highlights

The American College of Gastroenterology (ACG) continues to recommend colorectal cancer screening in average-risk adults ages 50 to 75 years but now also suggests it in those ages 45 to 49 years.
March 2021

Highlights

A systematic review and network meta-analysis focused on alosetron, eluxadoline, ramosetron, and rifaximin in adult patients who had irritable bowel syndrome (IBS) with diarrhea or mixed stool.
April 2019

Result Page: Prev   1   2   3   4   5   6   7   8   9   10   Next